NDC 50090-5960-01 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5960
- Requested NDC
- 50090-5960-01
- Package NDCs from labels
- 50090-5960-0, 50090-5960-2, 50090-5960-1, 50090-5960-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2024-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5960-0 | Losartan Potassium and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 50090-5960-1 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 50090-5960-2 | Losartan Potassium and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5960 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240511_1bb08103-04ee-47a6-a9ad-290e169feb51.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5960-0 | EA - Each | 50090-5960 | 236055f1-416d-4476-9b0a-73e1e0487b4e | 1 | 2022-07-06 |
| 50090-5960-1 | EA - Each | 50090-5960 | 7d68ca49-dafa-447b-a05c-8d0bc0a3e141 | 1 | 2022-07-06 |
| 50090-5960-2 | EA - Each | 50090-5960 | 4e10ae2d-dd32-475b-9ed6-a7938f3dac25 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f7091c54-0984-7f6e-e053-6394a90afb4d | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f68d211d-d802-6c78-e053-2995a90a90d7 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 3984e6b9-2d88-47f0-af09-cce428bba14f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM 50 mg | LOSARTAN POTASSIUM | Northwind Health Company, LLC | c29d999d-adc9-6c66-e053-2995a90a1fc3 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db895e64-3f97-9201-e053-2a95a90ac7ef | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9ced981-d791-6600-e053-2995a90ace3b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9de3627-9aa2-65c8-e053-2995a90ab5ec | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9df33c8-4ea7-5d1c-e053-2a95a90aecf7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9dfae69-9ce7-0c6b-e053-2a95a90aace8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | bdca31d3-60b1-4659-aef7-56530b4f9039 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Youth Glow Vitamin C CC Cream Sunscreen SPF 50 - Fair | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47428cd4-fbad-ba7a-e063-6394a90a1c5c | 2025-12-31 | Warnings | 15FIX9V2JP |
| Youth Glow Vitamin C CC Cream Sunscreen SPF 50 - Medium | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47433a62-91e0-b031-e063-6294a90a0d49 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Fair | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4743b6a9-4d79-1b2b-e063-6394a90a9710 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Light Medium | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4744e501-f12a-6d25-e063-6394a90a2574 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Medium | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47456bf5-9f6c-e6a5-e063-6294a90a7054 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Tan | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4745ab56-abaa-42de-e063-6394a90a6310 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Tan Deep | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4745ebec-acb0-77c4-e063-6394a90aee07 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Deep | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47461ad3-a11e-2a11-e063-6294a90a0f8f | 2025-12-31 | Warnings | 15FIX9V2JP |
| Sei Bella CC Brightening Creme Light | OCTINOXATE 7.5%, TITANIUM DIOXIDE 5%, ZINC OXIDE 1% | Melaleuca Inc. | 6894b9d9-a5b5-4c98-e053-2991aa0a9ca2 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Sei Bella CC Brightening Creme Fair | OCTINOXATE 7.5%, TITANIUM DIOXIDE 5%, ZINC OXIDE 1% | Melaleuca Inc. | 6892952a-d032-30bf-e053-2a91aa0a3bba | 2025-12-31 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.